GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $36.78 $42.85 Monday, 22nd Apr 2024 CLDX stock ended at $38.85. This is 2.29% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 3.71% from a day low at $37.99 to a day high of $39.40.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Feb 16, 2021 $24.69 $25.37 $24.06 $25.25 735 394
Feb 12, 2021 $23.50 $24.96 $23.30 $24.30 448 878
Feb 11, 2021 $23.19 $24.16 $22.75 $23.75 455 627
Feb 10, 2021 $22.55 $23.40 $21.98 $22.82 469 143
Feb 09, 2021 $24.35 $24.54 $22.34 $22.50 529 653
Feb 08, 2021 $24.02 $25.73 $23.84 $24.21 689 879
Feb 05, 2021 $23.76 $24.48 $23.11 $23.80 461 092
Feb 04, 2021 $22.55 $25.56 $22.34 $23.09 755 712
Feb 03, 2021 $21.74 $22.22 $21.56 $22.05 441 133
Feb 02, 2021 $21.61 $22.08 $20.81 $21.76 527 045
Feb 01, 2021 $21.87 $22.43 $20.70 $21.52 647 562
Jan 29, 2021 $20.83 $22.23 $20.81 $21.62 1 276 011
Jan 28, 2021 $20.25 $20.95 $19.73 $20.74 693 335
Jan 27, 2021 $19.49 $20.46 $19.10 $20.06 892 203
Jan 26, 2021 $18.85 $20.64 $18.84 $20.11 987 435
Jan 25, 2021 $17.95 $18.85 $17.61 $18.82 680 177
Jan 22, 2021 $17.66 $18.12 $17.35 $17.80 394 889
Jan 21, 2021 $18.88 $19.14 $17.31 $17.93 831 556
Jan 20, 2021 $18.06 $19.45 $17.79 $18.72 576 108
Jan 19, 2021 $17.56 $18.33 $17.46 $17.94 422 235
Jan 15, 2021 $17.88 $18.29 $17.37 $17.53 438 261
Jan 14, 2021 $17.65 $18.14 $17.50 $17.98 552 760
Jan 13, 2021 $18.10 $18.28 $17.46 $17.56 513 182
Jan 12, 2021 $17.58 $18.14 $17.36 $18.05 271 697
Jan 11, 2021 $17.50 $17.87 $17.19 $17.36 650 896
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT